New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions of older Americans because Medicare is forbidden to cover such medications. As obesity rates rise among older adults, some lawmakers say the United States cannot afford to keep a decades-old law that prohibits Medicare from paying for new weight loss drugs, including Wegovy and Zepbound. A look at the debate around if — and how — Medicare should cover obesity drugs: WHAT OBESITY DRUGS ARE ON THE MARKET AND HOW DO THEY WORK?
New weight loss drugs are out of reach for millions of older Americans because Medicare won t pay times-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from times-news.com Daily Mail and Mail on Sunday newspapers.
New weight loss drugs are out of reach for millions of older Americans because Medicare won t pay kob.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kob.com Daily Mail and Mail on Sunday newspapers.